Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Myles Wolf is an Associate Professor of Medicine at the University of Miami Miller School of Medicine, USA. He is Director of Clinical Research in the Division of Nephrology and Hypertension, Director of the University of Miami Clinical Research Center and Assistant Dean for Translational and Clinical Research at the Miller School of Medicine, USA.
Dr Wolf received his medical degree from the State University School of New York Downstate in Brooklyn, New York, USA. He completed internship and residency training in internal medicine at the Massachusetts General Hospital and nephrology fellowship at the Massachusetts General Hospital and the Brigham and Women's Hospital in Boston, Massachusetts, USA. During his research fellowship training in nephrology, Dr Wolf obtained a Masters of Medical Sciences in Clinical and Physiological Investigation from Harvard Medical School, also in Boston, Massachusetts.
The focus of Dr Wolf's research is disordered mineral metabolism across the spectrum of chronic kidney disease, including dialysis, kidney transplantation and earlier stages. His research has been published in several leading general medicine and subspecialty journals including the New England Journal of Medicine, JAMA, the Journal of Clinical Investigation, Circulation, Journal of the American Society of Nephrology and Kidney International, among others. His primary contributions have been in the area of hormonal regulation of phosphorus and vitamin D homeostasis. He has helped to characterize the physiological role of fibroblast growth factor 23 (FGF23) in health and in chronic kidney disease and the impact of elevated FGF23 levels on adverse clinical outcomes in patients with kidney disease.
During the past decade, Dr Wolf's research on mineral metabolism has been supported by grants from the American Heart Association, the National Kidney Foundation, the American Society of Nephrology, and the National Institutes of Health, and he has served as primary mentor for students, residents, fellows and faculty members involved in patient-oriented research. He serves on the editorial boards for Journal of the American Society of Nephrology and Clinical Journal of the American Society of Nephrology and as an ad hoc peer reviewer for several other journals. Dr Wolf has been invited to deliver numerous national and international lectures on his research, has been the recipient of teaching and mentoring awards, and in 2010, he was elected to the American Society of Clinical Investigation.
David A. Bushinsky
David A. Bushinsky, is the John J. Kuiper Distinguished Professor of Medicine and of Pharmacology and Physiology at the University of Rochester School of Medicine, USA. He is Chief of the Nephrology Division at the University of Rochester Medical Center and Associate Chair for Academic Affairs in the Department of Medicine.
Dr Bushinsky has published over 100 peer-reviewed articles and over 100 invited reviews, chapters and editorials focusing on disorders of divalent ion metabolism. He has developed a strain of rats that exhibit genetic hypercalciuria, the most common metabolic abnormality in humans with nephrlithiasis, and spontaneously form kidney stones. The pathophysiolgy of the hypercalciuria closely parallels that of man and is thus a useful model to study stone formation in humans. He has also extensively studied the mechanism by which acid induces physicochemical bone dissolution and cell-mediated resorption. His research has been consistently funded by grants from the National Institutes of Health for over 2 decades. Dr Bushinsky has lectured throughout the world on stone formation, effects of acid on bone and other disorders of divalent ion metabolism.
Dr Bushinsky received his medical degree from Tufts University School of Medicine in Boston, Massachusetts, USA. He completed an internship and residency at Tufts New England Medical Center Hospital in Boston, Massachusetts. He also completed a fellowship in clinical nephrology and a research fellowship in nephrology at Tufts New England Medical Center Hospital in Boston, Massachusetts.
Dr Bushinsky is a member of a number of organizations including the Association of American Physicians and the American Society for Clinical Investigation.
Orson W. Moe
Orson Moe received his medical degree from the University of Toronto, Canada and is currently Professor of Internal Medicine and Physiology at the University of Texas Southwestern Medical Center, USA. He is the Director of the Charles and Jane Pak Center of Mineral Metabolism and Clinical Research, USA. He is also a member of the Nephrology Division at Southwestern, USA. Dr Moe is the holder of the Charles and Jane Pak Chair in Mineral Metabolism Research and the Donald Seldin Professorship in Clinical Investigation.
Dr Moe conducts both basic science and patient-oriented research on renal physiology and metabolism, and epithelial biology. Dr Moe's research strives to cross from the level of the whole patient, to animal and cell culture models, and down to single molecules.
In addition to editing Current Opinion in Nephrology and Hypertension, Dr Moe also serves on the editorial board of the American Journal of Physiology and edits the textbook “The Kidney by Seldin and Giebisch”. Dr Moe is currently a member of the American Society of Clinical Research, American Association of Physicians, American Society of Nephrology, American Physiologic Society, and Biophysical Society.
Susan Quaggin graduated from the Faculty of Medicine at the University of Toronto, Canada in 1988 and received her specialty degree in Internal Medicine in 1992. She completed her sub-specialty training in Nephrology in 1993, at the University of Toronto, and did a post-doctoral fellowship at Yale University, USA where she studied the genetic basis of kidney development. In 1997, she returned to Toronto to do a second post-doctoral fellowship in mouse genetics in the laboratory of Janet Rossant. She is a Professor in the Department of Medicine, a Senior Scientist at the Samuel Lunenfeld Research Institute and is a practicing Nephrologist at St. Michael's Hospital, Canada. She holds a Canada Research Chair Tier II in Vascular Biology and a Premier's Research of Excellence Award and was recently named the Gabor-Zellerman Professor in Renal Medicine.
Dr Quaggin serves as a councillor of the ASCI (2010–2013), an Associate Editor of the Journal of the American Society of Nephrology, and is an editorial board member of the Journal of Clinical Investigation, Stem Cells, Disease Models and Mechanisms, and the American Journal of Kidney Disease and is Chair of the Endothelial Phenotypes Gordon Conference, 2012.
Susan's research program focuses on the genetic pathways required to establish and maintain the glomerular filtration barrier – a highly selective filter that separates the blood from the urinary space. To understand the pathways and interactions between different cell types in the glomerulus that are critical to set up the filtration barrier, Susan's research team has developed a number of genetic tools that permit cell and time-specific manipulation of gene expression. Her research laboratory is funded by the Canadian Institutes of Health Research, the Kidney Foundation of Canada, the National Cancer Institute of Canada, and the NIH.